NCT00730899

Brief Summary

The purpose of this study is to determine whether polymorphisms in G protein subunits, namely Galphas and Galphaq, are associated with altered cardiac performance in heart failure patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2008

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2008

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 8, 2008

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

August 8, 2008

Status Verified

August 1, 2008

Enrollment Period

2.7 years

First QC Date

August 4, 2008

Last Update Submit

August 4, 2008

Conditions

Outcome Measures

Primary Outcomes (1)

  • genotype dependent change of hemodynamic variables

    one day

Secondary Outcomes (1)

  • all cause mortality

    60 days

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with coronary artery disease scheduled for coronary artery bypass grafting in the university hospital

You may qualify if:

  • clinical diagnosis of coronary artery disease
  • patients scheduled for coronary artery bypass grafting

You may not qualify if:

  • emergency operation
  • combined vitium

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital

Essen, North Rhine-Westphalia, 45147, Germany

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

whole blood

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Jürgen Peters, MD

    University Hospital, Essen

    STUDY DIRECTOR

Central Study Contacts

Ulrich H Frey, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

August 4, 2008

First Posted

August 8, 2008

Study Start

May 1, 2008

Primary Completion

January 1, 2011

Study Completion

June 1, 2011

Last Updated

August 8, 2008

Record last verified: 2008-08

Locations